Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas

Background: Epidermal growth factor receptor is overexpressed in most pediatric high-grade gliomas (HGG). Since erlotinib had shown activity in adults with HGG, we conducted a phase II trial of erlotinib and local radiotherapy (RT) in children with newly diagnosed HGG. Methods: Following maximum sur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Qaddoumi, Ibrahim, Kocak, Mehmet, Pai Panandiker, Atmaram S., Armstrong, Gregory T., Wetmore, Cynthia, Crawford, John R., Lin, Tong, Boyett, James M., Kun, Larry E., Boop, Fredrick A., Merchant, Thomas E., Ellison, David W., Gajjar, Amar, Broniscer, Alberto
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2014
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978340/
https://ncbi.nlm.nih.gov/pubmed/24744992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars